EX-10.1
from 10-Q
2 pages
This Limited Waiver, Dated as of June 30, 2025 (“Limited Waiver”), Is Made by Onconetix, Inc (The “Company”) and Veru Inc. (The “Holder”). Whereas, Reference Is Hereby Made to a Certain Promissory Note, Dated as of April 19, 2023, and Which Was Originally Due on April 19, 2024 (The “April 2024 Promissory Note”); Whereas, Reference Is Hereby Made to a Certain Promissory Note, Dated as of April 19, 2023, Which Was Originally Due on September 30, 2024 (“September 2024 Promissory Note” and Together With the April 2024 Promissory Note, the “Promissory Notes”);
12/34/56
EX-10.2
from 10-Q
2 pages
This Limited Waiver, Dated as of April 23, 2025 (“Limited Waiver”), Is Made by Onconetix, Inc (The “Company”) and Veru Inc. (The “Holder”). Whereas, Reference Is Hereby Made to a Certain Promissory Note, Dated as of April 19, 2023, and Which Was Originally Due on April 19, 2024 (The “April 2024 Promissory Note”);
12/34/56
EX-10.1
from 10-Q
2 pages
This Limited Waiver, Dated as of March 31, 2025 (“Limited Waiver”), Is Made by Onconetix, Inc (The “Company”) and Veru Inc. (The “Holder”). Whereas, Reference Is Hereby Made to a Certain Promissory Note, Dated as of April 19, 2023, and Which Was Originally Due on April 19, 2024 (The “April 2024 Promissory Note”);
12/34/56
EX-10.1
from 8-K
1 page
Very Truly Yours, Veru Inc. By: /S/ Mitchell S. Steiner Mitchell S. Steiner, M.D., Chairman, President and Chief Executive Officer Accepted and Agreed as of the Date Set Forth Above: Lincoln Park Capital Fund, LLC By: Lincoln Park Capital, LLC By: Rockledge Capital Corporation By: /S/ Joshua Scheinfeld Name: Joshua Scheinfeld Title: President
12/34/56
